English
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

diabetes mellitus type 1/phosphatase

The link is saved to the clipboard
10 results

Use of islet glucose-6-phosphatase related protein as a diagnostic tool and therapeutic target for autoimmune diabetes

Only registered users can translate articles
Log In/Sign up
REFERENCE TO SEQUENCE LISTING This application contains a Sequence Listing submitted as an electronic text file named "2848.sub.--56_PUS_DIV_ST25.txt" having a size in bytes of 19 KB, and created on Feb. 18, 2010. The information contained in this electronic file is hereby incorporated by reference

Inhibitors of protein tyrosine phosphatase

Only registered users can translate articles
Log In/Sign up
FIELD OF THE INVENTION The present invention comprises small molecular weight, non-peptidic inhibitors of Protein Tyrosine Phosphatase 1 (PTP1) which are useful for the treatment and/or prevention of Non-Insulin Dependent Diabetes Mellitus (NIDDM). BACKGROUND OF THE INVENTION The mechanism of

Inhibitors of protein tyrosine phosphatase

Only registered users can translate articles
Log In/Sign up
The present invention comprises small molecular weight, non-peptidic inhibitors of Protein Tyrosine Phosphatase 1 (PTP1) which are useful for the treatment and/or prevention of Non-Insulin Dependent Diabetes Mellitus (NIDDM). BACKGROUND OF THE INVENTION The mechanism of insulin action depends

Modulators of protein tyrosine phosphatases (PTPases)

Only registered users can translate articles
Log In/Sign up
FIELD OF THE INVENTION The present invention relates to novel thienopyridines, to methods for their preparation, to compositions comprising the compounds, to the use of these compounds as medicaments and their use in therapy, where such compounds of Formula 1 are pharmacologically useful inhibitors

Protein tyrosine phosphatase inhibitors and methods of use thereof

Only registered users can translate articles
Log In/Sign up
FIELD OF THE INVENTION This invention relates to the field of protein tyrosine phosphatase inhibition. BACKGROUND OF THE INVENTION This invention relates to a novel class of phosphonic acid derivatives that are inhibitors of PTP-1B. Reversible protein tyrosine phosphorylation, coordinated by the

Protein tyrosine phosphatase inhibitors and methods of use thereof

Only registered users can translate articles
Log In/Sign up
FIELD OF THE INVENTION This invention relates to the field of protein tyrosine phosphatase inhibition. BACKGROUND OF THE INVENTION This invention relates to a novel class of phosphonic acid derivatives that are inhibitors of PTP-1B. Reversible protein tyrosine phosphorylation, coordinated by the

Antigens targeted by prevalent pathogennic T cells in type 1 diabetes and uses thereof

Only registered users can translate articles
Log In/Sign up
BACKGROUND (1) Field of the Invention The present invention generally relates to diagnosis and therapy of type 1 diabetes. More specifically, the invention provides methods of diagnosis, prevention and therapy of type 1 diabetes based on the identification of the islet (3 cell antigen targeted by

Islet cell antigen 1851

Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION Detection of specific autoantigens in prediabetic individuals has been used as a predictive marker to identify, before clinical onset and significant .beta.-cell loss has occurred, those at greater risk of developing IDDM (Gorsuch et al., Lancet 2: 1363-65, 1981;

Islet cell antigen 1851

Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION Insulin-dependent diabetes mellitus (IDDM) is a disease resulting from the autoimmune destruction of the insulin-producing .beta.-cells of the pancreas. Studies directed at identifying the autoantigen(s) responsible for .beta.-cell destruction have generated several

C-glycosylpolyphenol antidiabetic agents, effect on glucose tolerance and interaction with beta-amyloid. therapeutic applications of the synthesized agent(s) and of Genista tenera ethyl acetate extracts containing some of those agents

Only registered users can translate articles
Log In/Sign up
CROSS-REFERENCE TO RELATED APPLICATIONS This application is a .sctn.371 national stage of PCT International Application No. PCT/IB2013/051916, filed Mar. 11, 2013, claiming priority of Portuguese Patent Application No. 106202, filed Mar. 9, 2012, the contents of each of which are hereby incorporated
Join our facebook page

The most complete medicinal herbs database backed by science

  • Works in 55 languages
  • Herbal cures backed by science
  • Herbs recognition by image
  • Interactive GPS map - tag herbs on location (coming soon)
  • Read scientific publications related to your search
  • Search medicinal herbs by their effects
  • Organize your interests and stay up do date with the news research, clinical trials and patents

Type a symptom or a disease and read about herbs that might help, type a herb and see diseases and symptoms it is used against.
*All information is based on published scientific research

Google Play badgeApp Store badge